RHAMM Antibodies

Santa Cruz Biotechnology delivers a wide array of RHAMM monoclonal antibodies for investigating the receptor for hyaluronic acid-mediated motility (RHAMM) in various biological processes. RHAMM monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RHAMM plays an essential role in cell motility, proliferation, and tissue repair, with significant implications in cancer progression and metastasis. The interaction between RHAMM and hyaluronic acid influences cellular behavior, making RHAMM an important target for therapeutic interventions in various diseases. Research focused on RHAMM continues to reveal new insights into tumor biology and potential treatment approaches. RHAMM monoclonal antibodies enable precise detection and analysis of protein expression patterns across different experimental conditions. Investigating RHAMM's molecular mechanisms helps advance understanding of its role in normal physiology and disease states. RHAMM monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.